Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility.

Ji-Hyun KangJi-Eun LeeSo-Jeong JeongChun-Woong ParkDong-Wook KimKwon-Yeon Weon

Published in: Drug design, development and therapy (2022)

The results imply that high-dose RIV can be administered regardless of the meal, reducing the risk of changing the drug effect due to the patient's administration mistake.

Keyphrases

high dose
venous thromboembolism
low dose
atrial fibrillation
case report
drug delivery
stem cell transplantation
pulmonary embolism
ionic liquid
capillary electrophoresis
drug induced